Department of Urology, China Japan Union Hospital, Jilin University, Changchun, 130033, Jilin, China.
Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
Clin Transl Oncol. 2017 Dec;19(12):1438-1446. doi: 10.1007/s12094-017-1693-3. Epub 2017 Jun 6.
Urinary bladder cancer is the second commonly diagnosed genitourinary malignancy. Previously, bio-molecular alterations have been observed within certain locations such as chromosome 9, retinoblastoma gene and fibroblast growth factor receptor-3. Solute carrier family 14 member 1 (SLC14A1) gene encodes the type-B urea transporter (UT-B) which facilitates the passive movement of urea across cell membrane, and has recently been related with human malignancies, especially for bladder cancer. Herein, we discussed the SLC14A1 gene and UT-B protein properties, aiming to elucidate the expression behavior of SLC14A1 in human bladder cancer. Furthermore, by reviewing some well-established theories regarding the carcinogenesis of bladder cancer, including several genome wide association researches, we have bridged the mechanisms of cancer development with the aberrant expression of SLC14A1. In conclusion, the altered expression of SLC14A1 gene in human urothelial cancer may implicate its significance as a novel target for research.
膀胱癌是第二大常见的泌尿生殖系统恶性肿瘤。先前,在某些位置观察到生物分子改变,如染色体 9、视网膜母细胞瘤基因和成纤维细胞生长因子受体 3。溶质载体家族 14 成员 1(SLC14A1)基因编码 B 型尿素转运体(UT-B),可促进尿素穿过细胞膜的被动运动,最近与人类恶性肿瘤,特别是膀胱癌有关。在此,我们讨论了 SLC14A1 基因和 UT-B 蛋白特性,旨在阐明 SLC14A1 在人膀胱癌中的表达行为。此外,通过回顾膀胱癌发生的一些既定理论,包括几项全基因组关联研究,我们将癌症发展的机制与 SLC14A1 的异常表达联系起来。总之,人尿路上皮癌中 SLC14A1 基因的改变表达可能暗示其作为研究新靶标的重要性。